{
  "id": 7864507,
  "title": "Cytosorbents president & COO Vincent Capponi buys $12,536 in stock",
  "url": "https://urgent.news/2026/09/16/cytosorbents-president-coo-vincent-capponi-buys-12-536-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-16T20:30:56.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/cytosorbents-president--coo-vincent-capponi-buys-12536-in-stock-93CH-4904510"
  },
  "original_language": "en",
  "account": "Cytosorbents Corp President and COO Vincent Capponi made a stock purchase of 2,073 shares on September 14, 2026, valuing the acquisition at $12,536. This brought Capponi's direct beneficial ownership to 40,387 shares, following a 67% drop in the stock's price over the past year. The company's market cap stands at $18 million. Capponi's purchase also includes various RSUs that will convert to common stock. The financial performance of Cytosorbents improved in Q2 2026 with a modest revenue increase and better gross margins, despite flat revenue year-over-year.",
  "summary": null,
  "key_points": [
    "Vincent Capponi bought 2,073 Cytosorbents shares for $12,536 on September 14, 2026",
    "His ownership increased to 40,387 shares after 67% stock price drop",
    "Q2 2026 performance showed revenue increase and better gross margins"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}